Long Term Care Journal
Monday, May 21, 2018
FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure - FDA Press Releases
FDA approves Doptelet (avatrombopag) to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical procedure.
from Food and Drug Administration--Press Releases https://ift.tt/2rYWkmQ
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment